Bioton S.A. Logo

Bioton S.A.

Develops and manufactures recombinant human insulin for global diabetes care solutions.

BIO | WAR

Overview

Corporate Details

ISIN(s):
PLBIOTN00029
LEI:
259400I5R1L3OPCGII81
Country:
Poland
Address:
Warszawa Starościńska 5, 02-516 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioton S.A. is an innovative biotechnology company specializing in providing comprehensive solutions for diabetes care. The company's core activities include the research, development, manufacturing, and commercialization of pharmaceutical products, with a primary focus on recombinant human insulin. Bioton manages the entire drug production process, from advanced R&D and the synthesis of active pharmaceutical ingredients to the distribution of finished medicinal products. Recognized as a leader in the Polish market, the company is also one of the top commercial manufacturers of recombinant human insulin globally, operating from its modern production facility near Warsaw.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bioton S.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 15:55
Report Publication Announcement
Zmiana terminu publikacji skonsolidowanego "rozszerzonego" raportu półrocznego …
Polish 774 bytes
2025-07-29 17:13
Board/Management Information
Romuald Harwas życiorys
English 150.3 KB
2025-07-29 17:13
Board/Management Information
Powołanie Członka Zarządu - Content (PL)
Polish 1.1 KB
2025-07-29 17:04
Board/Management Information
Rezygnacja Członka Zarządu - Content (PL)
Polish 346 bytes
2025-07-25 15:29
Major Shareholding Notification
Otrzymanie zawiadomienia na podstawie art. 69 Ustawy o ofercie publicznej i war…
Polish 2.5 KB
2025-06-24 12:04
Registration Form
Xia Kaiguo CV
English 131.3 KB
2025-06-24 12:04
Post-Annual General Meeting Information
Powołanie osoby nadzorującej BIOTON S.A. - Content (PL)
Polish 1.2 KB
2025-06-23 14:50
Post-Annual General Meeting Information
Uchwały ZWZ z dnia 23.06.2025
Polish 258.4 KB
2025-06-23 14:50
Post-Annual General Meeting Information
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie BIOTON S.A. w dniu 23 czerwc…
Polish 276 bytes
2025-06-23 14:41
Declaration of Voting Results & Voting Rights Announcements
Lista Akcjonariuszy ZWZ Bioton S.A. 5%
Polish 117.5 KB
2025-06-23 14:41
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ BIOTON S.…
Polish 363 bytes
2025-05-30 11:53
Registration Form
CV kandydata
English 131.3 KB
2025-05-30 11:53
Pre-Annual General Meeting Information
Ogłoszenie ZWZ 23 czerwca 2025 zmiana porządku obrad
Polish 390.1 KB
2025-05-30 11:53
Pre-Annual General Meeting Information
Zmiana porządku obrad ZWZ Bioton S.A. zwołanego na dzień 23.06.2025 r. - Conten…
Polish 869 bytes
2025-05-23 18:56
Board/Management Information
Rezygnacja osoby nadzorującej Bioton S.A.
Polish 811 bytes

Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bioton S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.